Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Moody's Corporation (MCO) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Moody's CorporationTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Moody's Corporation vs Health Care Select Sector SPDR Fund — how do they compare? Moody's Corporation trades at $464.23 (market cap $79.44B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Moody's Corporation is the larger of the two by market cap, and Moody's Corporation pays a 0.9% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moody's Corporation for 132 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

MCOXLV
Market Cap
$79.44B$43.48B
Volume
526,68411,121,431
Sector
Financials—
52-Week High
$539.61$175.68
52-Week Low
$412.23$141.95
Typical Hold Time
132 Days100 Days
Enterprise Value
$85.46B—
Dividend Yield
0.9%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Moody's Corporation

MCO trades at $458.69, up 2.01% today, with a bearish technical signal but strong fundamentals. Revenue grew to $7.72B in 2025, with net income margin expanding to 34.25%. Recent news highlights Moody's top RiskTech100 ranking and expansion into Asia-Pacific via a PhilRatings stake. The stock faces resistance near $461, with support at $454.

Outlook remains positive given consistent earnings beats, high profitability, and a $536.40 analyst price target implying 17% upside. Risks include high valuation multiples and macroeconomic sensitivity. Institutional sentiment is bullish with 56% buy ratings, though technical indicators suggest near-term caution.

Health Care Select Sector SPDR Fund

XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.

XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MCO
30% Buy70% Sell
Avg holding period · 132 Days
XLV
44% Buy56% Sell
Avg holding period · 100 Days

About Moody's Corporation

Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.

Read more on MCO →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →